patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Emma - you somehow forgot to post the "NEWS" yesterday
Pluristem Therapeutics Inc sets a new 52-week low 11:00 a.m. 10/08/2008 Provided By Trading Activity Pluristem Therapeutics Inc (PSTI) crossed below its 52-week low of $0.64 on 11:00 AM ET on October 08, 2008. Content Provided by Third Parties The content on this page is provided by third parties and not Fidelity. Fidelity did not prepare and does not endorse such content. Delayed quotes are delayed at least 20 minutes. Historical prices provided by Reuters. Earnings estimates provided by Thomson Financial. Fundamental data provided by Standard & Poor's Compustat®. Proprietary ratings and ratings information are provided by third parties that are not affiliated with Fidelity. More About Third Party Content. Copyright 1998–2008 FMR LLC. All rights reserved. Terms of Use Privacy Security Site Map
Share
New Message
Please login to post a reply